Research on serotonin and suicidal behavior: neuroendocrine and molecular approaches.

Abstract:

:We carried out two studies to test the hypothesis that altered central serotonergic function, as assessed by lower prolactin (PRL) response to fenfluramine (D-FEN), is more closely associated with suicidal behavior than a particular psychiatric diagnosis. A D-FEN test was performed in 85 major depressed inpatients, 33 schizophrenic inpatients, and 18 healthy controls. We showed that PRL response to D-FEN is a marker of suicidality, regardless of psychiatric disorder. We then examined the association en the serotonin (5-hydroxytryptamine) receptor 5-HT(2A) gene polymorphism (T102C) and suicide in a sample of Brazilian psychiatric inpatients (95 with schizophrenia, 78 with major depression) and 52 healthy controls. No differences were found in genotypic frequencies across patients and controls. Overall, no differences were found between patients with (n=66) and without (n=107) a history of suicide attempt. We also compared patients with a history of severe suicide attempts (lethality>3; n=32) and patients without such a history (n=107), but they did not exhibit different genotypic frequencies either. These results show thai the 5-HT(2A) gene polymorphism (T102C) may not be involved in the genetic susceptibility to suicidal behavior.

authors

Corrêa H,Romano-Silva MA,Duval F,Campi-Azevedo AC,Lima V,Macher JP

subject

Has Abstract

pub_date

2002-12-01 00:00:00

pages

408-16

issue

4

eissn

1294-8322

issn

1958-5969

journal_volume

4

pub_type

杂志文章
  • Epilepsy research: a window onto function to and dysfunction of the human brain.

    abstract::As one of the most common neurological disorders, epilepsy has devastating behavioral, social, and occupational consequences and is associated with accumulating brain damage and neurological deficits. Epilepsy comprises a large number of syndromes, which vary greatly with respect to their etiology and clinical feature...

    journal_title:Dialogues in clinical neuroscience

    pub_type: 杂志文章,评审

    doi:

    authors: Beck H,Elger CE

    更新日期:2008-01-01 00:00:00

  • Depression in late life: psychiatric-medical comorbidity.

    abstract::The links between late-life depression and the medical comorbidities that are often associated with it can be divided into two paths. The path from medical illness to depression reflects general mechanisms related to stress, disability, and loss, as well as more specific physiological mechanisms, including those relat...

    journal_title:Dialogues in clinical neuroscience

    pub_type: 杂志文章

    doi:

    authors: Katz IR

    更新日期:1999-09-01 00:00:00

  • Pursuit of the "truth" about mental illness: the significance of findings in neuropsychiatric research, and lessons from the past.

    abstract::Technology in genetics and brain imaging has advanced so rapidly that it is difficult to be knowledgeable about all the new tools being used in the pursuit of progress toward understanding and treating mental illness. While findings from new studies remain promising, caution is needed with regard to their current appl...

    journal_title:Dialogues in clinical neuroscience

    pub_type: 社论

    doi:

    authors: DeLisi LE

    更新日期:2014-12-01 00:00:00

  • Internet interventions for depression: new developments.

    abstract::A wide range of Internet interventions, mostly grounded in methods of cognitive behavioral therapy, have been developed and tested for several mental disorders. The evidence to date shows that these interventions are effective in reducing symptoms of depression. Metaanalyses report small-to-medium effect sizes when In...

    journal_title:Dialogues in clinical neuroscience

    pub_type: 杂志文章,评审

    doi:

    authors: Schröder J,Berger T,Westermann S,Klein JP,Moritz S

    更新日期:2016-06-01 00:00:00

  • Psychosis related to neurological conditions: pro and cons of the dis- / mis-connectivity models of schizophrenia.

    abstract::Schizophrenia is still a condition with obscure causes and psychopathology. This paper aims to discuss the "disconnectivity" hypothesis in relation to some neurological conditions which are known to alter brain connectivity, as well as mimicking some aspects of the disorder. After a short historical introduction to th...

    journal_title:Dialogues in clinical neuroscience

    pub_type: 杂志文章,评审

    doi:

    authors: Foucher JR,Luck D

    更新日期:2006-01-01 00:00:00

  • Neuroimaging in anxiety disorders.

    abstract::Over the last few years, neuroimaging techniques have contributed greatly to the identification of the structural and functional neuroanatomy of anxiety disorders. The amygdala seems to be a crucial structure for fear and anxiety, and has consistently been found to be activated in anxiety-provoking situations. Apart f...

    journal_title:Dialogues in clinical neuroscience

    pub_type: 杂志文章,评审

    doi:

    authors: Holzschneider K,Mulert C

    更新日期:2011-01-01 00:00:00

  • Cannabinoids and their therapeutic applications in mental disorders
.

    abstract::Mental disorders represent a significant public health burden worldwide due to their high prevalence, chronically disabling nature, and substantial impact on quality of life. Despite growing knowledge of the pathological mechanisms that underlie the development of these disorders, a high percentage of patients do not ...

    journal_title:Dialogues in clinical neuroscience

    pub_type: 杂志文章

    doi:10.31887/DCNS.2020.22.3/pfadda

    authors: Scherma M,Muntoni AL,Riedel G,Fratta W,Fadda P

    更新日期:2020-09-01 00:00:00

  • The development concept of "endogenous psychoses".

    abstract::Several structural deviances in the brain in "endogenous psychoses" have been described over the last decades. The enlargement of the lateral ventricles and the subtle structural deficits in temporobasal and orbital frontal structures (hypofrontality) are reasonably well established in the majority of schizophrenic pa...

    journal_title:Dialogues in clinical neuroscience

    pub_type: 杂志文章,评审

    doi:

    authors: Beckmann H,Jakob H,Senitz D

    更新日期:2006-01-01 00:00:00

  • Nonpharmacological treatment of dyscognition in schizophrenia: effects 
of aerobic exercise
.

    abstract::Cognitive symptoms are a core feature of schizophrenia and are related to an unfavorable disease outcome. So far, there are no satisfactory pharmacological approaches to address cognitive symptoms. For some time now, aerobic exercise has been demonstrated in various trials to be a promising candidate for this indicati...

    journal_title:Dialogues in clinical neuroscience

    pub_type: 杂志文章,meta分析,评审

    doi:10.31887/DCNS.2019.21.3/aschmitt

    authors: Maurus I,Röh A,Falkai P,Malchow B,Schmitt A,Hasan A

    更新日期:2019-09-01 00:00:00

  • SPECT assessment of brain activation induced by caffeine: no effect on areas involved in dependence.

    abstract::Caffeine is not considered addictive, and in animals it does not trigger metabolic increases or dopamine release in brain areas involved in reinforcement and reward. Our objective was to measure caffeine effects on cerebral perfusion in humans using single photon emission computed tomography with a specific focus on a...

    journal_title:Dialogues in clinical neuroscience

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:

    authors: Nehlig A,Armspach JP,Namer IJ

    更新日期:2010-01-01 00:00:00

  • Dementia prevention and reserve against neurodegenerative disease.

    abstract::Similar to other complex disorders, the etiology of Alzheimer disease is multifactorial and characterized by an interplay of biological and environmental risk and protective factors. Potentially modifiable risk factors have emerged from epidemiological research and strategies to prevent neurodegeneration and dementia ...

    journal_title:Dialogues in clinical neuroscience

    pub_type: 杂志文章

    doi:

    authors: Perneczky R

    更新日期:2019-03-01 00:00:00

  • Imaging genetics of schizophrenia.

    abstract::Recent years have seen an explosive growth of interest in the application of imaging genetics to understand neurogenetic mechanisms of schizophrenia. Imaging genetics applies structural and functional neuroimaging to study subjects carrying genetic risk variants that relate to a psychiatric disorder. We review selecte...

    journal_title:Dialogues in clinical neuroscience

    pub_type: 杂志文章,评审

    doi:

    authors: Meyer-Lindenberg A

    更新日期:2010-01-01 00:00:00

  • Common genetic risk factors for psychiatric and simatic disorders.

    abstract::There is increasing knowledge about considerable comorbidity between psychiatric and somatic diseases, questioning whether variations in genes could be predisposing factors for both conditions. With respect to the multiple interactions between brain and body investigations have centered on variants in several candidat...

    journal_title:Dialogues in clinical neuroscience

    pub_type: 杂志文章

    doi:

    authors: Bondy B

    更新日期:2003-06-01 00:00:00

  • Animal models for screening anxiolytic-like drugs: a perspective.

    abstract::Contemporary biological psychiatry uses experimental animal models to increase our understanding of affective disorder pathogenesis. Modern anxiolytic drug discovery mainly targets specific pathways and molecular determinants within a single phenotypic domain. However, greater understanding of the mechanisms of action...

    journal_title:Dialogues in clinical neuroscience

    pub_type: 杂志文章,评审

    doi:

    authors: Bourin M

    更新日期:2015-09-01 00:00:00

  • Medical and substance-related comorbidity in bipolar disorder: translational research and treatment opportunities.

    abstract::It is well established that individuals with bipolar disorder are differentially affected by substance-related as well as medical disorders (ie, cardiometabolic disorders, respiratory disorders, neurological disorders, and infectious diseases). Emerging evidence indicates that some comorbid conditions (eg, diabetes me...

    journal_title:Dialogues in clinical neuroscience

    pub_type: 杂志文章,评审

    doi:

    authors: McIntyre RS,Nguyen HT,Soczynska JK,Lourenco MT,Woldeyohannes HO,Konarski JZ

    更新日期:2008-01-01 00:00:00

  • Treatment mechanisms: traditional and new antipsychotic drugs.

    abstract::The first generation of antipsychotic drugs was discovered in the 1960s and 1970s, These agents were effective in treating psychosis, but were accompanied by significant side effects, including severe parkinsonism and akathisia. Second-generation antipsychotics were introduced in the 1990s, These drugs have at least e...

    journal_title:Dialogues in clinical neuroscience

    pub_type: 杂志文章

    doi:

    authors: Tamminga CA

    更新日期:2000-09-01 00:00:00

  • Constructive memory: past and future.

    abstract::Human memory is not a literal reproduction of the past, but instead relies on constructive processes that are sometimes prone to error and distortion. Understanding of constructive memory has accelerated during recent years as a result of research that has linked together its cognitive and neural bases. This article f...

    journal_title:Dialogues in clinical neuroscience

    pub_type: 杂志文章,评审

    doi:

    authors: Schacter DL

    更新日期:2012-03-01 00:00:00

  • DNA methylation and demethylation as targets for antipsychotic therapy.

    abstract::Schizophrenia (SZ) and bipolar disorder (BPD) patients show a downregulation of GAD67, reelin (RELN), brain-derived neurotrophic factor (BDNF), and other genes expressed in telencephalic GABAergic and glutamatergic neurons. This downregulation is associated with the enrichment of 5-methylcytosine and 5-hydroxymethylcy...

    journal_title:Dialogues in clinical neuroscience

    pub_type: 杂志文章,评审

    doi:

    authors: Guidotti A,Grayson DR

    更新日期:2014-09-01 00:00:00

  • The genetics of obsessive-compulsive disorder: a review.

    abstract::Obsessive-compulsive disorder (OCD) is a serious psychiatric disorder that affects approximately 2% of the populations of children and adults. Family aggregation studies have demonstrated that OCD is familial, and results from twin studies demonstrate that the familiality is due in part to genetic factors. Only three ...

    journal_title:Dialogues in clinical neuroscience

    pub_type: 杂志文章,评审

    doi:

    authors: Pauls DL

    更新日期:2010-01-01 00:00:00

  • Sex-biased cellular signaling: molecular basis for sex differences in neuropsychiatric diseases.

    abstract::The recognition that there are fundamental biological sex differences that extend beyond those that define sexual behavior and reproductive function has inspired the drive toward inclusion of both sexes in research design. This is supported by an underlying clinical rationale that studying both sexes is necessary to e...

    journal_title:Dialogues in clinical neuroscience

    pub_type: 杂志文章,评审

    doi:

    authors: Valentino RJ,Bangasser DA

    更新日期:2016-12-01 00:00:00

  • Enhancing synaptic plasticity and cellular resilience to develop novel, improved treatments for mood disorders.

    abstract::There is mounting evidence that recurrent mood disorders - once considered "good prognosis diseases"- are, in fact, often very severe and life-threatening illnesses. Furthermore, although mood disorders have traditionally been conceptualized as neurochemical disorders, there is now evidence from a variety of sources d...

    journal_title:Dialogues in clinical neuroscience

    pub_type: 杂志文章

    doi:

    authors: Quiroz JA,Manji HK

    更新日期:2002-03-01 00:00:00

  • Lighting a path: genetic studies pinpoint neurodevelopmental mechanisms in autism and related disorders.

    abstract::In this review, we outline critical molecular processes that have been implicated by discovery of genetic mutations in autism. These mechanisms need to be mapped onto the neurodevelopment step(s) gone awry that may be associated with cause in autism. Molecular mechanisms include: (i) regulation of gene expression; (ii...

    journal_title:Dialogues in clinical neuroscience

    pub_type: 杂志文章,评审

    doi:

    authors: Pescosolido MF,Yang U,Sabbagh M,Morrow EM

    更新日期:2012-09-01 00:00:00

  • Expression profiling of drug response--from genes to pathways.

    abstract::Understanding individual response to a drug-what determines its efficacy and tolerability-is the major bottleneck in current drug development and clinical trials. Intracellular response and metabolism, for example through cytochrome P-450 enzymes, may either enhance or decrease the effect of different drugs, dependent...

    journal_title:Dialogues in clinical neuroscience

    pub_type: 杂志文章,评审

    doi:

    authors: Herwig R,Lehrach H

    更新日期:2006-01-01 00:00:00

  • Childhood predictors of states of anxiety.

    abstract::Development of the characteristics of social phobia often requires a diathesis in the form of a temperamental bias. A behavioral profile marked by vigorous motor activity and crying to unfamiliar stimuli at 4 months of age - called high reactivity- is characteristic of about 20% of healthy, Caucasian infants. This pat...

    journal_title:Dialogues in clinical neuroscience

    pub_type: 杂志文章

    doi:

    authors: Kagan J

    更新日期:2002-09-01 00:00:00

  • Functional neuroimaging and schizophrenia: a view towards effective connectivity modeling and polygenic risk.

    abstract::We review critical trends in imaging genetics as applied to schizophrenia research, and then discuss some future directions of the field. A plethora of imaging genetics studies have investigated the impact of genetic variation on brain function, since the paradigm of a neuroimaging intermediate phenotype for schizophr...

    journal_title:Dialogues in clinical neuroscience

    pub_type: 杂志文章,评审

    doi:

    authors: Birnbaum R,Weinberger DR

    更新日期:2013-09-01 00:00:00

  • Cytokines, neurophysiology, neuropsychology, and psychiatric symptoms.

    abstract::Recent research has overcome the old paradigms of the brain as an immunologically privileged organ, and of the exclusive role of neurotransmitters and neuropeptides as signal transducers in the central nervous system. Growing evidence suggests that the signal proteins of the immune system - the cytokines - are also in...

    journal_title:Dialogues in clinical neuroscience

    pub_type: 杂志文章

    doi:

    authors: Schwarz MJ

    更新日期:2003-06-01 00:00:00

  • Experimental models of stress.

    abstract::Illustrating the complexity of the stress response and its multifaceted manifestations is the leading idea of this overview of experimental paradigms used for stress induction in laboratory animals. The description of key features of models based on naturalistic stressors, pharmacological challenges, and genomic manip...

    journal_title:Dialogues in clinical neuroscience

    pub_type: 杂志文章,评审

    doi:

    authors: Patchev VK,Patchev AV

    更新日期:2006-01-01 00:00:00

  • Cellular basis of memory for addiction.

    abstract::DESPITE THE IMPORTANCE OF NUMEROUS PSYCHOSOCIAL FACTORS, AT ITS CORE, DRUG ADDICTION INVOLVES A BIOLOGICAL PROCESS: the ability of repeated exposure to a drug of abuse to induce changes in a vulnerable brain that drive the compulsive seeking and taking of drugs, and loss of control over drug use, that define a state o...

    journal_title:Dialogues in clinical neuroscience

    pub_type: 杂志文章,评审

    doi:

    authors: Nestler EJ

    更新日期:2013-12-01 00:00:00

  • Depression and associated physical diseases and symptoms.

    abstract::Depression can occur in association with virtually all the other psychiatric and physical diagnoses. Physical illness increases the risk of developing severe depressive illness. There are two broadly different mechanisms. The most obvious has a psychological or cognitive mechanism. Thus, the illness may provide the li...

    journal_title:Dialogues in clinical neuroscience

    pub_type: 杂志文章,评审

    doi:

    authors: Goodwin GM

    更新日期:2006-01-01 00:00:00

  • The impact of classification on psychopharmacology and biological psychiatry.

    abstract::Nosological classification in psychiatry, as it is currently applied, does not facilitate biological and psychopharmacological research.• Syndromal acuity has disappeared. Consequently, it is impossible to determine: (i) vi/hether a particular drug affects a particular symptom configuration; (ii) what exactly the beha...

    journal_title:Dialogues in clinical neuroscience

    pub_type: 杂志文章

    doi:

    authors: van Praag HM

    更新日期:1999-12-01 00:00:00